CRISPR gene therapy increases haemoglobin and fetal haemoglobin in sickle cell disease, reducing vaso occlusive events in ...

UC San Diego researchers have created a new system that reveals specific categories of potentially risky mutations resulting from CRISPR edits. This high magnification image reveals CRISPR-based DNA ...

Functional genomics is central to modern drug discovery, yet high attrition rates persist. In this article, Dr Salman ...

In late April 2026, analysts highlighted expectations for higher year-over-year earnings and revenue at CRISPR Therapeutics ahead of its March-quarter report, alongside strong launch metrics for ...

CRISPR-based genome engineering revolutionized the gene-editing field by making experimental workflows considerably easier, faster, and more efficient than previous methods. Still, generating reliable ...

Live-cell breakthrough: Munich scientists created a method to repeatedly read genetic activity from living cells, enabling long-term study without cell destruction. CRISPR reimagined: Hong Kong ...

First demonstration pairing single-cell targeted DNA and RNA readouts in multiplexed CRISPR cell therapy characterization.SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Mission Bio, the single-cell ...

New CRISPR paradigm: HKUST scientists created a DNA-guided Cas12a system that targets RNA, reversing the traditional RNA-guided DNA targeting model. Clinical potential: The SLEUTH platform ...

CORALVILLE, Iowa--(BUSINESS WIRE)--Bolstering its commitment to providing researchers with powerful tools to discover more about biology and advance medicine, global genomics solutions provider ...

CRISPR Therapeutics stock snapshot and recent performance CRISPR Therapeutics (CRSP) has drawn investor attention after its recent trading, with the stock last closing at US$57.69 and posting a 0.5% ...